Lab Groups Disagree With GAO That Medicare Will Be Overbilled For PAMA Test Payments

A coalition of US laboratories and diagnostic test-makers say it strongly disagrees with GAO’s conclusions that labs will be overbilling Medicare for future payments under the “Protecting Access To Medicare Act of 2014”, and sent a letter to GAO managers last week arguing its case.